A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019

by Alexander H. King, MS, Omar Mehkri, MD, Prabalini Rajendram, MD, Xiaofeng Wang, PhD, Vidula Vachharajani, MD, Abhijit Duggal, MD
Published 2021-05-01

Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis

by Prabalini Rajendram, MD, Gretchen L. Sacha, PharmD, Omar Mehkri, MD, Xiaofeng Wang, PhD, Xiaozhen Han, MS, Vidula Vachharajani, MD, Abhijit Duggal, MD
Published 2021-01-01

Single-Center Experience of Outcomes and Prescribing Patterns of IV Immunoglobulin Use in Critically Ill Patients

by Heather Torbic, PharmD, BCPS, BCCCP, Sinan Samir Abdul-Wahab, MD, MBBS, Sravanthi Ennala, MD, Nagamani Guduguntla, MBBS, Xiaozhen Han, MS, Xiaofeng Wang, PhD, Abhijit Duggal, MD, MPH, MSc, Sudhir Krishnan, MD
Published 2021-01-01

A Multicenter Evaluation of Survival After In-Hospital Cardiac Arrest in Coronavirus Disease 2019 Patients

by Abhishek Bhardwaj, MD, FACP, Mahmoud Alwakeel, MD, Talha Saleem, MD, Saira Afzal, MD, Sura Alqaisi, MD, Aisha R. Saand, MD, Hanan Al. Najjar, MD, Lori Griffiths, RN, MPH, Xiaozhen Han, MS, Xiaofeng Wang, PhD, Silvia Perez-Protto, MD, MS, FCCM, Benjamin S. Abella, MD, MPhil, FAHA, FACEP, David F. Gaieski, MD, FACEP, FCCM, Abhijit Duggal, MD, MPH, MSc, Francois Abi Fadel, MD, FACP, FCCP
Published 2021-05-01